# Beijing Wehand-bio Pharmaceutical Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/beijing-wehand-bio-pharmaceutical-co

- Industry: Pharmaceuticals
- Headquarters: Beijing, China
- Website: www.wehand-bio.cn
- Total disclosed funding: $4.9M
- Latest round: Series B (Jan 3, 2017)
- Investors on record: 4

## About

Based in Beijing, China and established in 2010, Beijing Wehand-bio Pharmaceutical Co.,Ltd focuses on developing and manufacturing medicine for curing diabetes mellitus, tumor and cardiovascular disease.

## Funding rounds

- Series B, Jan 3, 2017 — NLVC, Langsheng Investment
- Series B, Aug 27, 2015 — NLVC, Cowin Capital, Langsheng Investment, Lapam Capital
- Series A, Nov 7, 2014, $4.9M — Langsheng Investment

## Investors

- Langsheng Investment (https://capitalatlas.ai/funds/langsheng-investment) — Series A, Series B
- NLVC (https://capitalatlas.ai/funds/nlvc) — Series B
- Cowin Capital (https://capitalatlas.ai/funds/cowin-capital) — Series B
- Lapam Capital (https://capitalatlas.ai/funds/lapam-capital) — Series B